40%葡萄糖溶液与自体血补片胸膜固定术治疗肺切除术后持续漏气的比较:前瞻性随机对照研究
这项前瞻性随机对照研究纳入110例解剖性肺切除术后持续漏气患者,比较胸腔内注射40%葡萄糖溶液与自体血补片胸膜固定术的疗效。
要点
- 两组胸痛、残余气腔及再手术率无显著差异,安全性相当。
核心结论
- 胸腔内40%葡萄糖溶液治疗肺切除术后漏气的终止率高于自体血补片胸膜固定术,且安全性相当。
- 葡萄糖组术后住院时间短于自体血组。
研究设计与样本
- 共110例患者随机分为40%葡萄糖组(47例)和自体血组(63例),主要终点为术后漏气终止。
主要发现
- 未观察到严重感染并发症,残余气腔发生率和再手术率两组相当。
临床怎么用
- 对于肺切除术后持续漏气,可考虑胸腔内注射40%葡萄糖溶液作为自体血补片胸膜固定术的替代方案。
- 该处理可能缩短术后住院时间,但需关注胸痛发生情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Postoperative air leak is among the most common complications in thoracic surgery. Current management strategies are often suboptimal. Intrapleural administration of a glucose solution has emerged as a novel therapeutic approach; however, its clinical value has not been thoroughly investigated. This study aimed to compare the effectiveness of intrapleural 40% glucose solution vs autologous blood patch pleurodesis in managing postoperative air leak. METHODS: This prospective, randomized, controlled study enrolled patients who underwent anatomical lung resections (segmentectomy, lobectomy, or bilobectomy) at the Department of Thoracic Surgery, Poznan University of Medical Sciences, between November 2023 and December 2024. Patients with postoperative air leak were randomized to receive either 40% glucose (study group) or autologous blood (control group). The primary end-point was cessation of postoperative air leak. Secondary end-points included incidence of residual air space, chest pain, and reoperation. RESULTS: A total of 110 patients were included: 47 in the glucose group and 63 in the blood group. Glucose administration resulted in a higher rate of postoperative air leak resolution (95.7% vs 82.5%, P = .033; 95% CI: 2.2% to 24.2%). The glucose group had a shorter postoperative hospital stay (7 vs 9 days, P = .036). Chest pain occurred more frequently in the glucose group, but the difference was not statistically significant (10.6% vs 4.8%, P = .24). No major infectious complications were observed. Residual air space occurrence and reoperation rates were comparable. CONCLUSIONS: Intrapleural 40% glucose solution achieved a higher resolution rate of postoperative air leak compared to autologous blood patch pleurodesis, with a comparable safety profile. CLINICAL REGISTRATION NUMBER: NCT06936969 (ClinicalTrials.gov).
引用
- Skrzypczak PJ, Dobiecki T, Rozmiarek M, et al. Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for the Treatment of Postoperative Air Leak After Lung Resections: A Prospective Randomized Controlled Study. Eur J Cardiothorac Surg. 2025. PMID: 41191623. doi:10.1093/ejcts/ezaf382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。